AUSSENDER



SANOCHEMIA Pharmazeutika AG
Ansprechpartner: Bettina Zuccato
Tel.: +43 1 3191456-336
E-Mail: b.zuccato@sanochemia.at
Pressefach (161)

Rechtsgrundlage

Alle
Insiderinformationen
Unternehmensmitteilungen
Finanzberichte
Stimmrechtsmitteilungen
HV-Bekanntmachungen
Sonstige

Schlagwörter

SANOCHEMIA Pharmazeutika AG
Vertag
Unterzeichnung
Einbringungsvertrag
DE EN
09.12.2019 - 14:47 | SANOCHEMIA Pharmazeutika AG
Sanochemia Pharmazeutika AG aims for plan insolvency
23.10.2019 - 13:00 | SANOCHEMIA Pharmazeutika AG
Sanochemia announces veterinary asset deal
24.09.2019 - 11:21 | SANOCHEMIA Pharmazeutika AG
Positive Topline Results from Phase 2 STAR Study of Tolperisone in Acute Muscle Spasms of the Back in the U.S.
11.07.2019 - 09:18 | SANOCHEMIA Pharmazeutika AG
European patent granted for Vidon® in photodynamic diagnostics
02.07.2019 - 08:00 | SANOCHEMIA Pharmazeutika AG
Completion of Enrollment in the Phase 2 Study of Tolperisone in the U.S.
12.06.2019 - 09:26 | SANOCHEMIA Pharmazeutika AG
European patent granted for Vidon® in Photodynamic Therapy
23.10.2018 - 09:14 | SANOCHEMIA Pharmazeutika AG
Grant of patent for Vidon® Photodynamic Therapy of Bladder Cancer in the USA
07.05.2018 - 08:36 | SANOCHEMIA Pharmazeutika AG
Financing for clinical development of tolperisone USA successfully completed
25.01.2018 - 10:28 | SANOCHEMIA Pharmazeutika AG
Sanochemia signs license agreement for Vidon(R)
09.11.2017 - 13:57 | SANOCHEMIA Pharmazeutika AG
Successful Phase I Study Results Confirm the Non-Sedative Effects of Tolperisone
11.09.2017 - 10:00 | SANOCHEMIA Pharmazeutika AG
Sanochemia - Tolperisone USA: Start of clinical phase-I trial
18.07.2017 - 10:30 | SANOCHEMIA Pharmazeutika AG
Published data confirms the advantage of tolperisone in comparison to another muscle relaxant
10.03.2017 - 11:02 | SANOCHEMIA Pharmazeutika AG
SANOCHEMIA Pharmazeutika AG exhibits at the European Congress of Radiology (ECR) in Vienna
19.01.2017 - 11:09 | SANOCHEMIA Pharmazeutika AG
Advancement of Tolperisone's clinical development
13.01.2017 - 08:15 | SANOCHEMIA Pharmazeutika AG
Grant of patent for Vidon® Photodynamic Diagnosis of Bladder Cancer in the USA
|
99.116 Abonnenten
|
232.367 Meldungen
|
94.045 Pressefotos
|
Folgen Sie uns auf Twitter
|
Persönlicher Kontakt